200 related articles for article (PubMed ID: 18821707)
1. Epigallocatechin-3-gallate diminishes CCL2 expression in human osteoblastic cells via up-regulation of phosphatidylinositol 3-Kinase/Akt/Raf-1 interaction: a potential therapeutic benefit for arthritis.
Lin SK; Chang HH; Chen YJ; Wang CC; Galson DL; Hong CY; Kok SH
Arthritis Rheum; 2008 Oct; 58(10):3145-56. PubMed ID: 18821707
[TBL] [Abstract][Full Text] [Related]
2. Oncostatin M-induced CCL2 transcription in osteoblastic cells is mediated by multiple levels of STAT-1 and STAT-3 signaling: an implication for the pathogenesis of arthritis.
Kok SH; Hong CY; Kuo MY; Wang CC; Hou KL; Lin YT; Galson DL; Lin SK
Arthritis Rheum; 2009 May; 60(5):1451-62. PubMed ID: 19404962
[TBL] [Abstract][Full Text] [Related]
3. Epigallocatechin-3-gallate diminishes cytokine-stimulated Cyr61 expression in human osteoblastic cells: a therapeutic potential for arthritis.
Wu PH; Lin SK; Lee BS; Kok SH; Wang JH; Hou KL; Yang H; Lai EH; Wang JS; Hong CY
Rheumatology (Oxford); 2012 Nov; 51(11):1953-65. PubMed ID: 22843790
[TBL] [Abstract][Full Text] [Related]
4. MEK/ERK and signal transducer and activator of transcription signaling pathways modulate oncostatin M-stimulated CCL2 expression in human osteoblasts through a common transcription factor.
Lin SK; Kok SH; Yeh FT; Kuo MY; Lin CC; Wang CC; Goldring SR; Hong CY
Arthritis Rheum; 2004 Mar; 50(3):785-93. PubMed ID: 15022320
[TBL] [Abstract][Full Text] [Related]
5. An extract of green tea, epigallocatechin-3-gallate, reduces periapical lesions by inhibiting cysteine-rich 61 expression in osteoblasts.
Lee YL; Hong CY; Kok SH; Hou KL; Lin YT; Chen MH; Wang CC; Lin SK
J Endod; 2009 Feb; 35(2):206-11. PubMed ID: 19166774
[TBL] [Abstract][Full Text] [Related]
6. (--)-epigallocatechin gallate enhances prostaglandin F2alpha-induced VEGF synthesis via upregulating SAPK/JNK activation in osteoblasts.
Tokuda H; Takai S; Matsushima-Nishiwaki R; Akamatsu S; Hanai Y; Hosoi T; Harada A; Ohta T; Kozawa O
J Cell Biochem; 2007 Apr; 100(5):1146-53. PubMed ID: 17031857
[TBL] [Abstract][Full Text] [Related]
7. Tea polyphenol (-)-epigallocatechin 3-gallate suppresses heregulin-beta1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling.
Pan MH; Lin CC; Lin JK; Chen WJ
J Agric Food Chem; 2007 Jun; 55(13):5030-7. PubMed ID: 17539658
[TBL] [Abstract][Full Text] [Related]
8. Epigallocatechin-3 gallate induces growth inhibition and apoptosis in human breast cancer cells through survivin suppression.
Tang Y; Zhao DY; Elliott S; Zhao W; Curiel TJ; Beckman BS; Burow ME
Int J Oncol; 2007 Oct; 31(4):705-11. PubMed ID: 17786300
[TBL] [Abstract][Full Text] [Related]
9. Catechins inhibit CXCL10 production from oncostatin M-stimulated human gingival fibroblasts.
Hosokawa Y; Hosokawa I; Ozaki K; Nakanishi T; Nakae H; Matsuo T
J Nutr Biochem; 2010 Jul; 21(7):659-64. PubMed ID: 19616927
[TBL] [Abstract][Full Text] [Related]
10. Regulation of interleukin-1beta-induced chemokine production and matrix metalloproteinase 2 activation by epigallocatechin-3-gallate in rheumatoid arthritis synovial fibroblasts.
Ahmed S; Pakozdi A; Koch AE
Arthritis Rheum; 2006 Aug; 54(8):2393-401. PubMed ID: 16869002
[TBL] [Abstract][Full Text] [Related]
11. (-)-Epigallocatechin-3-gallate inhibits monocyte chemotactic protein-1 expression in endothelial cells via blocking NF-kappaB signaling.
Hong MH; Kim MH; Chang HJ; Kim NH; Shin BA; Ahn BW; Jung YD
Life Sci; 2007 May; 80(21):1957-65. PubMed ID: 17379255
[TBL] [Abstract][Full Text] [Related]
12. (-)-Epigallocatechin gallate reduces transforming growth factor beta-stimulated HSP27 induction through the suppression of stress-activated protein kinase/c-Jun N-terminal kinase in osteoblasts.
Hayashi K; Takai S; Matsushima-Nishiwaki R; Hanai Y; Kato K; Tokuda H; Kozawa O
Life Sci; 2008 May; 82(19-20):1012-7. PubMed ID: 18407296
[TBL] [Abstract][Full Text] [Related]
13. Phosphatidylinositol-3 kinase/Akt and GSK-3 mediated cytoprotective effect of epigallocatechin gallate on oxidative stress-injured neuronal-differentiated N18D3 cells.
Koh SH; Kim SH; Kwon H; Kim JG; Kim JH; Yang KH; Kim J; Kim SU; Yu HJ; Do BR; Kim KS; Jung HK
Neurotoxicology; 2004 Sep; 25(5):793-802. PubMed ID: 15288510
[TBL] [Abstract][Full Text] [Related]
14. (-)-Epigallocatechin-3-gallate suppresses osteoclast differentiation and ameliorates experimental arthritis in mice.
Morinobu A; Biao W; Tanaka S; Horiuchi M; Jun L; Tsuji G; Sakai Y; Kurosaka M; Kumagai S
Arthritis Rheum; 2008 Jul; 58(7):2012-8. PubMed ID: 18576345
[TBL] [Abstract][Full Text] [Related]
15. Naringin-induced bone morphogenetic protein-2 expression via PI3K, Akt, c-Fos/c-Jun and AP-1 pathway in osteoblasts.
Wu JB; Fong YC; Tsai HY; Chen YF; Tsuzuki M; Tang CH
Eur J Pharmacol; 2008 Jul; 588(2-3):333-41. PubMed ID: 18495116
[TBL] [Abstract][Full Text] [Related]
16. Pro-apoptotic effect of epigallo-catechin-3-gallate on B lymphocytes through regulating BAFF/PI3K/Akt/mTOR signaling in rats with collagen-induced arthritis.
Liu D; Li P; Song S; Liu Y; Wang Q; Chang Y; Wu Y; Chen J; Zhao W; Zhang L; Wei W
Eur J Pharmacol; 2012 Sep; 690(1-3):214-25. PubMed ID: 22760071
[TBL] [Abstract][Full Text] [Related]
17. [Epigallocatechin-3-gallate interferes with EBV-encoding AP-1 signal transduction pathway].
Zhao Y; Wang H; Zhao XR; Luo FJ; Tang M; Cao Y
Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):393-7. PubMed ID: 15355641
[TBL] [Abstract][Full Text] [Related]
18. Simvastatin inhibits cytokine-stimulated Cyr61 expression in osteoblastic cells: a therapeutic benefit for arthritis.
Kok SH; Hou KL; Hong CY; Wang JS; Liang PC; Chang CC; Hsiao M; Yang H; Lai EH; Lin SK
Arthritis Rheum; 2011 Apr; 63(4):1010-20. PubMed ID: 20191585
[TBL] [Abstract][Full Text] [Related]
19. Epigallocatechin gallate (EGCG) attenuates high glucose-induced insulin signaling blockade in human hepG2 hepatoma cells.
Lin CL; Lin JK
Mol Nutr Food Res; 2008 Aug; 52(8):930-9. PubMed ID: 18496818
[TBL] [Abstract][Full Text] [Related]
20. Regulation of urokinase plasminogen activator by epigallocatechin-3-gallate in human fibrosarcoma cells.
Kim MH; Jung MA; Hwang YS; Jeong M; Kim SM; Ahn SJ; Shin BA; Ahn BW; Jung YD
Eur J Pharmacol; 2004 Mar; 487(1-3):1-6. PubMed ID: 15033370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
